Pier Paolo Mattogno

Dr. Pier Paolo Mattogno

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SMSalvatore Marino
Salvatore Marino
GMGrazia Menna
Grazia Menna
RBRina Di Bonaventura
Rina Di Bonaventura
LLLucia Lisi
Lucia Lisi
PMPier Paolo Mattogno
Pier Paolo Mattogno
Giuseppe Maria Della PepaGiuseppe Maria Della Pepa
Giuseppe Maria Della Pepa
Background and aim: While many components of the ECM have been isolated and characterized, its modifications in the specific setting of GBMs have only been recently explored in the literature. The aim of this paper is to provide a systematic review on the topic and to assess the ECM’s role in shaping tumoral development. Methods: An online literature search was launched on PubMed/Medline and Scopus using the research string “((Extracellular matrix OR ECM OR matrix receptor OR matrix proteome) AND (glioblastoma OR GBM) AND (tumor invasion OR tumor infiltration))”, and a systematic review was conducted in accordance with the PRISMA-P guidelines. Results: The search of the literature yielded a total of 693 results. The duplicate records were then removed (n = 13), and the records were excluded via a title and abstract screening; 137 studies were found to be relevant to our research question and were assessed for eligibility. Upon a full-text review, 59 articles were finally included and were summarized as follows based on their focus: (1) proteoglycans; (2) fibrillary proteins, which were further subdivided into the three subcategories of collagen, fibronectin, and laminins; (3) glycoproteins; (4) degradative enzymes; (5) physical forces; (6) and glioma cell and microglia migratory and infiltrative patterns. Conclusions: Our systematic review demonstrates that the ECM should not be regarded anymore as a passive scaffold statically contributing to mechanical support in normal and pathological brain tissue but as an active player in tumor-related activity.

12 September 2021 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
RBRina Di Bonaventura
Rina Di Bonaventura
Nicola MontanoNicola Montano
Nicola Montano
MGMartina Giordano
Martina Giordano
MGMarco Gessi
Marco Gessi
SGSimona Gaudino
Simona Gaudino
AOAlessandro Olivi
Alessandro Olivi
Brain biopsy is the gold standard in order to establish the diagnosis of unresectable brain tumors. Few studies have investigated the long-term outcomes of biopsy patients. The aim of this single-institution-based study was to assess the concordance between radiological and histopathological diagnoses, and the long-term patient outcome. Ninety-three patients who underwent brain biopsy in the last 5 years were analyzed. We included patients treated with stereotactically guided needle, open, and neuroendoscopic biopsies. Most patients (86%) received needle biopsy. Gliomas and primary brain lymphomas comprised 88.2% of cases. The diagnostic yield was 95.7%. Serious complication and death rates were 3.2% and 2.1%, respectively. The concordance rate between radiological and histological diagnoses was 93%. Notably, the positive predictive value of radiological diagnosis of lymphoma was 100%. Biopsy allowed specific treatment in 72% of cases. Disease-related neurological worsening was the main reason that precluded adjuvant treatment. Adjuvant treatment, in turn, was the strongest prognostic factor, since the median overall survival was 11 months with vs. 2 months without treatment (p = 0.0002). Finally, advanced molecular evaluations can be obtained on glioma biopsy specimens to provide integrated diagnoses and individually tailored treatments. We conclude that, despite the huge advances in imaging techniques, biopsy is required when an adjuvant treatment is recommended, particularly in gliomas.

1 August 2013 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
PFPaolo Frassanito
Paolo Frassanito
PBPasquale De Bonis
Pasquale De Bonis
PMPier Paolo Mattogno
Pier Paolo Mattogno
AMAnnunziato Mangiola
Annunziato Mangiola
MNMariangela Novello
Mariangela Novello
CACarmelo Anile
Carmelo Anile

1 January 2013 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
PBPasquale De Bonis
Pasquale De Bonis
AMAnnunziato Mangiola
Annunziato Mangiola
APAngelo Pompucci
Angelo Pompucci
RFRita Formisano
Rita Formisano
PMPier Paolo Mattogno
Pier Paolo Mattogno
CACarmelo Anile
Carmelo Anile

1 January 2013 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
PBPasquale De Bonis
Pasquale De Bonis
GTGianpiero Tamburrini
Gianpiero Tamburrini
AMAnnunziato Mangiola
Annunziato Mangiola
APAngelo Pompucci
Angelo Pompucci
PMPier Paolo Mattogno
Pier Paolo Mattogno
CACarmelo Anile
Carmelo Anile

1 January 2017
Verified
Book Chapter
Closed access
PDF file
PMPier Paolo Mattogno
Pier Paolo Mattogno
GBGiuseppe Barbagallo
Giuseppe Barbagallo
GIGerardo Iacopino
Gerardo Iacopino
GPGaetano Pappalardo
Gaetano Pappalardo
Giuseppe La RoccaGiuseppe La Rocca
Giuseppe La Rocca
MVMassimiliano Visocchi
Massimiliano Visocchi